JPY1,943.00
1.99% yesterday
Tokyo, Sep 27, 08:10 am CET
ISIN
JP3197600004
Symbol
4528
Sector
Industry

Ono Pharmaceutical Target price 2024 - Analyst rating & recommendation

Ono Pharmaceutical Classifications & Recommendation:

Buy
17%
Hold
42%
Sell
42%

Ono Pharmaceutical Price Target

Target Price JPY2,216.18
Price JPY1,943.00
Potential
Number of Estimates 11
11 Analysts have issued a price target Ono Pharmaceutical 2025 . The average Ono Pharmaceutical target price is JPY2,216.18. This is higher than the current stock price. The highest price target is
JPY4,370.00 124.91%
register free of charge
, the lowest is
JPY1,800.00 7.36%
register free of charge
.
A rating was issued by 12 analysts: 2 Analysts recommend Ono Pharmaceutical to buy, 5 to hold and 5 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Ono Pharmaceutical stock has an average upside potential 2025 of . Most analysts recommend the Ono Pharmaceutical stock at Sell or hold.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Mar '24 2025
Estimates
Revenue Billion JPY 502.67 484.54
12.41% 3.61%
EBITDA Margin 36.15% 26.56%
4.77% 26.52%
Net Margin 24.91% 16.34%
2.74% 34.40%

11 Analysts have issued a sales forecast Ono Pharmaceutical 2025 . The average Ono Pharmaceutical sales estimate is

JPY485b
Unlock
. This is
3.16% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
JPY514b 2.73%
Unlock
, the lowest is
JPY453b 9.51%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 JPY503b 12.41%
2025
JPY485b 3.61%
Unlock
2026
JPY513b 5.94%
Unlock
2027
JPY524b 2.18%
Unlock
2028
JPY501b 4.56%
Unlock
2029
JPY490b 2.09%
Unlock

10 Analysts have issued an Ono Pharmaceutical EBITDA forecast 2025. The average Ono Pharmaceutical EBITDA estimate is

JPY129b
Unlock
. This is
26.89% lower
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
JPY155b 11.98%
Unlock
, the lowest is
JPY108b 38.63%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 JPY182b 7.04%
2025
JPY129b 29.19%
Unlock
2026
JPY140b 8.52%
Unlock
2027
JPY147b 5.33%
Unlock
2028
JPY129b 12.12%
Unlock
2029
JPY123b 4.89%
Unlock

EBITDA Margin

2024 36.15% 4.77%
2025
26.56% 26.52%
Unlock
2026
27.20% 2.41%
Unlock
2027
28.04% 3.09%
Unlock
2028
25.82% 7.92%
Unlock
2029
25.08% 2.87%
Unlock

5 Ono Pharmaceutical Analysts have issued a net profit forecast 2025. The average Ono Pharmaceutical net profit estimate is

JPY79.2b
Unlock
. This is
33.52% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
JPY90.8b 23.80%
Unlock
, the lowest is
JPY65.1b 45.35%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 JPY125b 15.49%
2025
JPY79.2b 36.75%
Unlock
2026
JPY78.1b 1.38%
Unlock
2027
JPY84.9b 8.71%
Unlock

Net Margin

2024 24.91% 2.74%
2025
16.34% 34.40%
Unlock
2026
15.22% 6.85%
Unlock
2027
16.19% 6.37%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Mar '24 2025
Estimates
Earnings Per Share JPY 266.61 168.63
15.49% 36.75%
P/E 11.52
EV/Sales 1.91

5 Analysts have issued a Ono Pharmaceutical forecast for earnings per share. The average Ono Pharmaceutical <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

JPY168.63
Unlock
. This is
33.52% lower
Unlock
than earnings per share in the financial year 2024. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
JPY193.27 23.80%
Unlock
, the lowest is
JPY138.61 45.35%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 JPY266.61 15.49%
2025
JPY168.63 36.75%
Unlock
2026
JPY166.30 1.38%
Unlock
2027
JPY180.79 8.71%
Unlock

P/E ratio

Current 7.66 37.11%
2025
11.52 50.39%
Unlock
2026
11.68 1.39%
Unlock
2027
10.75 7.96%
Unlock

Based on analysts' sales estimates for 2025, the Ono Pharmaceutical stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.85 33.93%
2025
1.91 3.34%
Unlock
2026
1.80 5.61%
Unlock
2027
1.77 2.13%
Unlock
2028
1.85 4.78%
Unlock
2029
1.89 2.14%
Unlock

P/S ratio

Current 1.82 40.08%
2025
1.88 3.26%
Unlock
2026
1.78 5.61%
Unlock
2027
1.74 2.13%
Unlock
2028
1.82 4.78%
Unlock
2029
1.86 2.14%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today